ERIN HOLLAND: Open Payments
NPI 1477189165 · GROESBECK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$426 in 21 payments from 10 companies in 2025. Trend: 2023 $257 · 2024 $2,010 · 2025 $426
Food & beverage: $426
| Company | Payments | Amount |
|---|---|---|
| MIMEDX Group, Inc. | 3 | $81 |
| Smith+Nephew, Inc. | 4 | $75 |
| Solventum Corporation | 3 | $69 |
| Lundbeck LLC | 4 | $61 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Kerecis Limited | 1 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| ConvaTec Inc. | 1 | $17 |
| Novo Nordisk Inc | 1 | $16 |
| Electromed, Inc. | 1 | $14 |
Products named: REXULTI, ACTIV.A.C., GRAFIX, COLLAGENASE SANTYL, Kerecis SurgiClose, FARXIGA, CONVATEC INC., Ozempic.
Industry payments across TX — which companies pay providers there.
